Mathai Mammen Insider Trading $THRX Innoviva, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mathai Mammen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mathai Mammen. Mathai Mammen is Senior VP, Research in Innoviva, Inc. ($THRX) and SVP, Research & Early Clin Dev in Innoviva, Inc. ($THRX) and SVP, Research & Development in Theravance Biopharma, Inc. ($TBPH) and Director in 10x Genomics, Inc. ($TXG).
Mathai Mammen in Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mathai Mammen: SVP, Research & Early Clin Dev, Senior VP, Research
Holdings: 308,936 shares
Latest Transaction: Jun 04 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mathai Mammen in Innoviva, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TXG, THRX, TBPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 21,000 | 0 | 308,936 | 287.9 K to 308.9 K (+7.29 %) |
| Jun 04 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 50,000 | 0 | 287,936 | 237.9 K to 287.9 K (+21.01 %) |
| May 12 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Gift | G | 0.00 | 1,200 | 0 | 237,936 | 239.1 K to 237.9 K (-0.50 %) |
| May 12 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 26.86 | 22,833 | 613,294 | 239,136 | 262 K to 239.1 K (-8.72 %) |
| Apr 29 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 37,500 | 0 | 261,969 | 224.5 K to 262 K (+16.71 %) |
| Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 16.00 | 29,250 | 468,000 | 0 | |
| Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 12.40 | 12,903 | 159,997 | 0 | |
| Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 16.00 | 29,250 | 468,000 | 224,469 | 195.2 K to 224.5 K (+14.98 %) |
| Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 12.40 | 12,903 | 159,997 | 195,219 | 182.3 K to 195.2 K (+7.08 %) |
| Feb 24 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 39.98 | 4,307 | 172,194 | 182,316 | 186.6 K to 182.3 K (-2.31 %) |
| Feb 19 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 40.04 | 4,600 | 184,184 | 186,623 | 191.2 K to 186.6 K (-2.41 %) |
| Feb 19 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 39.26 | 30,400 | 1,193,504 | 191,223 | 221.6 K to 191.2 K (-13.72 %) |
| Nov 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 36.40 | 4,569 | 166,312 | 222,073 | 226.6 K to 222.1 K (-2.02 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 16.00 | 18,750 | 300,000 | 0 | |
| Aug 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 16.00 | 18,750 | 300,000 | 226,642 | 207.9 K to 226.6 K (+9.02 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 35.89 | 3,813 | 136,849 | 207,892 | 211.7 K to 207.9 K (-1.80 %) |
| Aug 01 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 36.51 | 7,000 | 255,570 | 211,705 | 218.7 K to 211.7 K (-3.20 %) |
| Jul 26 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 5,000 | 0 | 218,705 | 213.7 K to 218.7 K (+2.34 %) |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 12.40 | 6,451 | 79,992 | 0 | |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 4,570 | 14,167 | 0 | |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 12.40 | 6,451 | 79,992 | 213,705 | 207.3 K to 213.7 K (+3.11 %) |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 4,570 | 14,167 | 207,254 | 202.7 K to 207.3 K (+2.25 %) |
| May 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 37.01 | 3,292 | 121,837 | 202,684 | 206 K to 202.7 K (-1.60 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 34.34 | 200 | 6,868 | 205,976 | 206.2 K to 206 K (-0.10 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 33.72 | 6,800 | 229,296 | 206,176 | 213 K to 206.2 K (-3.19 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 22.14 | 7,000 | 154,980 | 212,976 | 220 K to 213 K (-3.18 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 22.10 | 5,002 | 110,544 | 219,976 | 225 K to 220 K (-2.22 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 5,000 | 0 | 224,978 | 220 K to 225 K (+2.27 %) |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 2,655 | 8,231 | 0 | |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 11,855 | 36,751 | 0 | |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Gift | G | 0.00 | 460 | 0 | 219,978 | 220.4 K to 220 K (-0.21 %) |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 2,655 | 8,231 | 220,438 | 217.8 K to 220.4 K (+1.22 %) |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 11,855 | 36,751 | 217,783 | 205.9 K to 217.8 K (+5.76 %) |
| Nov 20 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 21.08 | 4,874 | 102,744 | 205,928 | 210.8 K to 205.9 K (-2.31 %) |
| Nov 16 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 5,161 | 15,999 | 0 | |
| Nov 16 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 5,161 | 15,999 | 210,802 | 205.6 K to 210.8 K (+2.51 %) |
| Nov 06 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 22.53 | 200 | 4,506 | 205,641 | 205.8 K to 205.6 K (-0.10 %) |
| Nov 06 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 21.42 | 6,800 | 145,656 | 205,841 | 212.6 K to 205.8 K (-3.20 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 5,000 | 0 | 212,641 | 207.6 K to 212.6 K (+2.41 %) |
| Aug 22 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 27.01 | 4,644 | 125,434 | 207,641 | 212.3 K to 207.6 K (-2.19 %) |
| Aug 15 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 26.15 | 3,108 | 81,274 | 212,285 | 215.4 K to 212.3 K (-1.44 %) |
| Aug 15 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 25.68 | 21,892 | 562,187 | 215,393 | 237.3 K to 215.4 K (-9.23 %) |
| May 22 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 20.33 | 3,832 | 77,905 | 237,285 | 241.1 K to 237.3 K (-1.59 %) |
| Feb 22 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 18.54 | 9,747 | 180,709 | 241,117 | 250.9 K to 241.1 K (-3.89 %) |
| Feb 17 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 5,000 | 0 | 250,864 | 245.9 K to 250.9 K (+2.03 %) |
| Nov 22 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 22.34 | 2,250 | 50,265 | 245,864 | 248.1 K to 245.9 K (-0.91 %) |
| Sep 02 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 8.53 | 3,225 | 27,493 | 0 | |
| Sep 02 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 8.53 | 3,225 | 27,493 | 248,114 | 244.9 K to 248.1 K (+1.32 %) |
| Aug 23 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 17.50 | 2,248 | 39,340 | 244,889 | 247.1 K to 244.9 K (-0.91 %) |
| May 24 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 25.48 | 2,245 | 57,203 | 247,137 | 249.4 K to 247.1 K (-0.90 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 22.50 | 3,240 | 72,900 | 249,382 | 252.6 K to 249.4 K (-1.28 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 23.12 | 3,701 | 85,567 | 252,622 | 256.3 K to 252.6 K (-1.44 %) |
| Feb 15 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 100,000 | 0 | 256,323 | 156.3 K to 256.3 K (+63.97 %) |
| Feb 15 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 12,500 | 0 | 156,323 | 143.8 K to 156.3 K (+8.69 %) |
| Jan 28 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 8.53 | 3,387 | 28,874 | 0 | |
| Jan 28 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 8.53 | 6,451 | 54,995 | 0 | |
| Jan 28 2011 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 8.53 | 9,838 | 83,869 | 143,823 | 134 K to 143.8 K (+7.34 %) |
| Nov 23 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 22.52 | 2,532 | 57,021 | 133,985 | 136.5 K to 134 K (-1.85 %) |
| Oct 28 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 12,500 | 0 | 136,517 | 124 K to 136.5 K (+10.08 %) |
| Sep 08 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 8.53 | 6,451 | 54,995 | 0 | |
| Sep 08 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 8.53 | 6,451 | 54,995 | 124,017 | 117.6 K to 124 K (+5.49 %) |
| Sep 02 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 12.84 | 4,416 | 56,701 | 117,566 | 122 K to 117.6 K (-3.62 %) |
| Aug 23 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 14.00 | 1,671 | 23,394 | 121,982 | 123.7 K to 122 K (-1.35 %) |
| May 21 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 13.02 | 1,673 | 21,782 | 123,653 | 125.3 K to 123.7 K (-1.33 %) |
| Feb 23 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 10.22 | 1,318 | 13,470 | 125,326 | 126.6 K to 125.3 K (-1.04 %) |
| Feb 12 2010 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 25,000 | 0 | 126,644 | 101.6 K to 126.6 K (+24.60 %) |
| Nov 24 2009 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 14.04 | 1,100 | 15,444 | 101,644 | 102.7 K to 101.6 K (-1.07 %) |
| Aug 21 2009 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 15.65 | 1,071 | 16,761 | 102,744 | 103.8 K to 102.7 K (-1.03 %) |
| May 22 2009 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 14.06 | 1,071 | 15,058 | 103,815 | 104.9 K to 103.8 K (-1.02 %) |
| Mar 24 2009 | THRX | Innoviva, Inc. | Mammen Mathai | Senior VP, Research | Grant | A | 0.00 | 37,000 | 0 | 104,886 | 67.9 K to 104.9 K (+54.50 %) |
| Feb 24 2009 | THRX | Innoviva, Inc. | Mammen Mathai | Senior VP, Research | Payment of Exercise | F | 14.87 | 1,183 | 17,591 | 67,886 | 69.1 K to 67.9 K (-1.71 %) |
| Jan 31 2008 | THRX | Innoviva, Inc. | Mammen Mathai | Senior VP, Research | Option Exercise | A | 19.80 | 100,000 | 1,980,000 | 100,000 | |
| Jan 31 2008 | THRX | Innoviva, Inc. | Mammen Mathai | Senior VP, Research | Grant | A | 0.00 | 11,000 | 0 | 69,069 | 58.1 K to 69.1 K (+18.94 %) |
Page: 1